BPC-157 should not be used by people who are pregnant or breastfeeding, who have active cancer (it promotes angiogenesis), who are under 18, or who have a known allergy to it
All injuries and conditions should be formally evaluated by a knowledgeable medical professional whereby standard treatments and additional therapeutic interventions may be considered with the diagnosis and treatment plan.
Clinical trials on peptide therapy for ovarian function have seen small gains in AMH levels in select groups with mixed results
, High-Tech Methods of Cytokine Imbalance Correction in Intervertebral Disc Degeneration, Int
What Makes Our BPC-157 Peptide Nasal Spray Different
Sikiric, P., Seiwerth, S., Grabarevic, Z., Rucman, R., Petek, M., Jagic, V., Turkovic, B., Rotkvic, I., Mise, S., Zoricic, I., Konjevoda, P., Perovic, D., Simicevic, V., Separovic, J., Hanzevacki, M., Ljubanovic, D., Artukovic, B., Bratulic, M., Tisljar, M., & Rekic, B